Article Versions Notes

Lu G, Liu Q, Gao T, Li J, Zhang J, Chen O, Cao C, Mao M, Xiao M, Zhang X, et al. Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway. Nutrients. 2022; 14(19):4017. https://doi.org/10.3390/nu14194017

Lu, Guangping, Qingbo Liu, Ting Gao, Jiahao Li, Jingjing Zhang, Ou Chen, Cong Cao, Min Mao, Mengjie Xiao, Xiaohui Zhang, and et al. 2022. "Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway" Nutrients 14, no. 19: 4017. https://doi.org/10.3390/nu14194017

Lu, G., Liu, Q., Gao, T., Li, J., Zhang, J., Chen, O., Cao, C., Mao, M., Xiao, M., Zhang, X., Wang, J., Guo, Y., Tang, Y., & Gu, J. (2022). Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway. Nutrients, 14(19), 4017. https://doi.org/10.3390/nu14194017